Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1Classical hematology 1

Conditions

Venous Thromboembolism 1Lung Neoplasms 1Esophageal Neoplasms 1

Interventions

Rivaroxaban 3apixaban 2Heparin, Low-Molecular-Weight 2Fondaparinux 2Enoxaparin 2Dalteparin 2enoxaparin sodium 1edoxaban 1Warfarin 1Tinzaparin 1Nadroparin 1Long-Term Synaptic Depression 1Hematologic Tests 1Educational Status 1Dabigatran 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Venous Thromboembolism × Nadroparin × Clear all
NCT01267305 2014-04-29

The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery

Shanghai Zhongshan Hospital

Phase NA Completed
362 enrolled
Classical hematologyGastrointestinalThoracic

Esophageal Neoplasms, Lung Neoplasms, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡